In Israel, weight-loss supplement with banned substance leads to hospitalization
Israel’s Ministry of Health warned about the danger of the unapproved weight-loss supplement G-Slim after a young person was hospitalized. As The Jerusalem Post reports, laboratory tests detected sibutramine in the product — a medicinal substance banned in Israel and a number of other countries.
High concentration of sibutramine
The ministry stated that no product containing sibutramine is registered in Israel. The substance was withdrawn from the markets of most countries after it was linked to an increased risk of heart attack and ischemic stroke.
According to the agency, one G-Slim capsule contains 53.8 milligrams of sibutramine. This is more than three times the amount of the substance in products that were previously withdrawn from circulation and banned.
More current news is available on the UA.News Telegram channel Telegram.
Israeli Ministry of Health warning
Among other risks of using sibutramine, the ministry named increased blood pressure, rapid heartbeat, anxiety, irritability, insomnia, and mental disorders. Such consequences could potentially pose a threat to life.
The agency urged people not to buy counterfeit and unregulated goods, and to purchase medicines, dietary supplements, and other health products only from authorized sellers, including pharmacies and pharmacy chains. Citizens were also asked to avoid purchasing such goods through social media, messaging app groups, and unfamiliar websites.
